---

Bill Title: Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Sponsorship: Partisan Bill (Democrat 43)

Status: (Introduced) 2026-05-14 - Referred to the House Committee on Energy and Commerce. [HR1285 Detail]

Download: US_Congress-2025-HR1285-Introduced.pdf

---